RA Capital Management Overview
- Investor Type
-
Asset Manager
- Status
-
Active
- Professionals
-
49
- Investments
-
616
- Portfolio
-
166
- Exits
-
299
RA Capital Management General Information
Company Description
Founded in 2004, RA Capital Management is an asset manager based in Boston, Massachusetts. The firm prefers to invest in healthcare, planetary health, and life science companies developing drugs, medical devices, services & research tools, and diagnostics, with a focus on those based in the United States and the European region. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.racap.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 200 Berkeley Street
- 18th Floor
- Boston, MA 02116
- United States
RA Capital Management Investments & Acquisitions (616)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Vitrivax | 19-Nov-2026 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Delix Therapeutics | 09-Nov-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Alethio Therapeutics | 05-Nov-2026 | Drug Discovery | Clinical Trials - General | |||
| Aclaris Therapeutics | 28-Oct-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Zai Lab | 27-Oct-2026 | Pharmaceuticals | Profitable | |||
| Star Therapeutics | 23-Oct-2026 | Biotechnology | Generating Revenue | |||
| Optivolt | 21-Oct-2026 | Alternative Energy Equipment | Generating Revenue | |||
| Estuary Biotherapeutics | 16-Oct-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Koloma | 15-Oct-2026 | Later Stage VC | Energy Production | Generating Revenue | ||
| Marea | 17-Sep-2026 | PIPE | Biotechnology | Clinical Trials - Phase 2 |
RA Capital Management Exits (299)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Windward Bio Group | 13-Nov-2026 | IPO | |
| Bambusa Therapeutics | 30-Oct-2026 | ||
| Bolt Biotherapeutics | 23-Oct-2026 | ||
| Be Biopharma | 05-Oct-2026 | ||
| Electra Therapeutics | 18-Sep-2026 | ||
| Ventricle Health | 01-Sep-2026 | ||
| Obsidian Therapeutics | 03-Aug-2026 | ||
| Scribe Therapeutics | 24-Jul-2026 | ||
| Kira Pharma | 16-Jul-2026 | Merger/Acquisition | |
| Vega Therapeutics | 06-Jul-2026 | Merger/Acquisition |
RA Capital Management Investments by Industry, Year, and Region
RA Capital Management Co-Investors (678)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 25 |
|
|
||
| Janus Henderson Investors |
|
|
|||
| Deep Track Capital |
|
|
|||
| BVF Partners |
|
|
|||
| Forbion |
|
|
RA Capital Management FAQs
-
What is RA Capital Management?
Founded in 2004, RA Capital Management is an asset manager based in Boston, Massachusetts.
-
When was RA Capital Management founded?
RA Capital Management was founded in 2004.
-
Where is RA Capital Management headquartered?
RA Capital Management is headquartered in Boston, MA.
-
What is RA Capital Management's total asset value?
RA Capital Management has around in total assets under management.
-
How many investments has RA Capital Management made?
RA Capital Management has made 616 investments.
-
What has RA Capital Management invested in?
RA Capital Management has made numerous investments in companies like Vitrivax, Delix Therapeutics, and Alethio Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has RA Capital Management invested in recently?
RA Capital Management's latest investment was on 19-Nov-2026 in Vitrivax, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process